Target intelligence / Profile preview

Hantaan virus envelope glycoprotein (None commonly used (Gn and Gc subunits may be abbreviated individually))

Target
None commonly used (Gn and Gc subunits may be abbreviated individually)
Molecular classification
Viral envelope glycoprotein, Class II fusion protein (Gc subunit), Other
01

Overview

The Hantaan virus envelope glycoprotein is a heterodimeric viral surface complex composed of two membrane-anchored subunits: Gn and Gc. Both are encoded by the viral M genomic segment and generated via cleavage from a single polyprotein precursor. These glycoproteins assemble into tetrameric spike lattices decorating the viral lipid envelope, mediating essential roles in host cell entry by interacting with cellular receptors (notably β3-integrins for pathogenic hantaviruses), facilitating receptor-mediated endocytosis, and catalyzing endosomal membrane fusion through conformational change, primarily attributed to the Gc subunit[1][2][3][5][6]. The glycoproteins are the exclusive viral targets of neutralizing antibodies and are central to vaccine and antiviral therapeutic designs[3][6][7]. They additionally engage host immune evasion mechanisms and direct the assembly and budding of new virions[5][8]. The Gn and Gc envelope glycoproteins are highly conserved among hantaviruses, with variations influencing pathogenic potential and immune recognition[2][3][5][6]. Their dysfunction or structural alteration can prevent viral infection, establishing them as key therapeutic targets for Hantaan virus and related hantavirus diseases.

Other names
Hantaan virus glycoproteinHantaan virus surface glycoproteinHantaan virus GnHantaan virus GcHTNV envelope glycoprotein
02

Mechanism of action

Neutralizing antibodies block glycoprotein-mediated cell entry and membrane fusion[3][6]. Fusion inhibitors would prevent the conformational change required for membrane fusion. Vaccine-induced antibodies prevent infection by binding to functional glycoprotein epitopes.

03

Biological functions

Virus entry into host cellsReceptor binding (cell attachment)Membrane fusionImmune evasionVirus assembly and budding
04

Disease associations

Infection (hemorrhagic fever with renal syndrome)Zoonotic pathogen
05

Safety considerations

Viral antigenic diversity poses a challenge for vaccine and antibody therapy development[3][6].Potential for immune escape mutations.Lack of cross-protection among divergent hantaviruses may limit broad protective strategies.
06

Interacting drugs

No approved drugs target HTNV glycoprotein directly as of 2025, but it is the main target for neutralizing antibodies and a focus for investigational vaccines and antibody therapies[3][6][7].
07

Biomarkers

No established clinical biomarkers for monitoring efficacy; neutralizing antibody titers against Gn/Gc assessed experimentally in vaccine/immunotherapy studies[3][7].

Beyond the preview

Go deeper on Hantaan virus envelope glycoprotein (None commonly used (Gn and Gc subunits may be abbreviated individually)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hantaan virus envelope glycoprotein (None commonly used (Gn and Gc subunits may be abbreviated individually)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call